| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | Quinoprotein_ADH-like_supfam | 2.25e-06 | 53 | 75 | 5 | IPR011047 | |
| Domain | Cyclin_Y | 1.59e-05 | 2 | 75 | 2 | IPR012399 | |
| Domain | WD_REPEATS_1 | 1.26e-04 | 278 | 75 | 7 | PS00678 | |
| Domain | WD_REPEATS_2 | 1.28e-04 | 279 | 75 | 7 | PS50082 | |
| Domain | WD_REPEATS_REGION | 1.28e-04 | 279 | 75 | 7 | PS50294 | |
| Domain | WD40_repeat_dom | 1.89e-04 | 297 | 75 | 7 | IPR017986 | |
| Domain | Spectrin_repeat | 2.11e-04 | 29 | 75 | 3 | IPR002017 | |
| Domain | Spectrin/alpha-actinin | 2.84e-04 | 32 | 75 | 3 | IPR018159 | |
| Domain | SPEC | 2.84e-04 | 32 | 75 | 3 | SM00150 | |
| Domain | STAT_TF_prot_interaction | 3.30e-04 | 7 | 75 | 2 | IPR013799 | |
| Domain | STAT_TF_DNA-bd_sub | 3.30e-04 | 7 | 75 | 2 | IPR012345 | |
| Domain | STAT | 3.30e-04 | 7 | 75 | 2 | IPR001217 | |
| Domain | STAT_TF_coiled-coil | 3.30e-04 | 7 | 75 | 2 | IPR015988 | |
| Domain | - | 3.30e-04 | 7 | 75 | 2 | 2.60.40.630 | |
| Domain | STAT_int | 3.30e-04 | 7 | 75 | 2 | SM00964 | |
| Domain | STAT_TF_DNA-bd | 3.30e-04 | 7 | 75 | 2 | IPR013801 | |
| Domain | STAT_bind | 3.30e-04 | 7 | 75 | 2 | PF02864 | |
| Domain | STAT_int | 3.30e-04 | 7 | 75 | 2 | PF02865 | |
| Domain | - | 3.30e-04 | 7 | 75 | 2 | 1.10.532.10 | |
| Domain | STAT_alpha | 3.30e-04 | 7 | 75 | 2 | PF01017 | |
| Domain | - | 3.30e-04 | 7 | 75 | 2 | 1.20.1050.20 | |
| Domain | - | 3.78e-04 | 333 | 75 | 7 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 3.92e-04 | 335 | 75 | 7 | IPR015943 | |
| Domain | STAT_TF_alpha | 4.39e-04 | 8 | 75 | 2 | IPR013800 | |
| Domain | WD40 | 6.07e-04 | 259 | 75 | 6 | PF00400 | |
| Domain | WD40 | 7.26e-04 | 268 | 75 | 6 | SM00320 | |
| Domain | WD40_repeat | 7.84e-04 | 272 | 75 | 6 | IPR001680 | |
| Domain | - | 9.45e-04 | 48 | 75 | 3 | 2.120.10.80 | |
| Domain | Kelch_2 | 1.21e-03 | 13 | 75 | 2 | IPR011498 | |
| Domain | Kelch_2 | 1.21e-03 | 13 | 75 | 2 | PF07646 | |
| Domain | Kelch-typ_b-propeller | 1.40e-03 | 55 | 75 | 3 | IPR015915 | |
| Domain | Kelch_1 | 2.81e-03 | 70 | 75 | 3 | PF01344 | |
| Domain | Kelch_1 | 2.81e-03 | 70 | 75 | 3 | IPR006652 | |
| Domain | Actinin_actin-bd_CS | 3.81e-03 | 23 | 75 | 2 | IPR001589 | |
| Domain | Spectrin | 3.81e-03 | 23 | 75 | 2 | PF00435 | |
| Domain | ACTININ_2 | 3.81e-03 | 23 | 75 | 2 | PS00020 | |
| Domain | ACTININ_1 | 3.81e-03 | 23 | 75 | 2 | PS00019 | |
| Domain | - | 4.00e-03 | 261 | 75 | 5 | 1.10.238.10 | |
| Domain | G-protein_beta_WD-40_rep | 4.85e-03 | 85 | 75 | 3 | IPR020472 | |
| Domain | CYCLINS | 5.62e-03 | 28 | 75 | 2 | PS00292 | |
| Domain | EF-hand-dom_pair | 5.95e-03 | 287 | 75 | 5 | IPR011992 | |
| Domain | EGF_LAM_2 | 6.44e-03 | 30 | 75 | 2 | PS50027 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_JAK_STAT_SIGNALING_PATHWAY | 1.22e-04 | 5 | 50 | 2 | M48987 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_JAK_STAT_SIGNALING_PATHWAY | 1.22e-04 | 5 | 50 | 2 | M48986 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PRL_JAK_STAT_SIGNALING_PATHWAY | 1.22e-04 | 5 | 50 | 2 | M49006 | |
| Pathway | REACTOME_INTERLEUKIN_9_SIGNALING | 1.83e-04 | 6 | 50 | 2 | MM15581 | |
| Pathway | REACTOME_INTERLEUKIN_21_SIGNALING | 1.83e-04 | 6 | 50 | 2 | MM15621 | |
| Pathway | REACTOME_STAT5_ACTIVATION | 2.56e-04 | 7 | 50 | 2 | M27953 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_JAK_STAT_SIGNALING_PATHWAY | 2.56e-04 | 7 | 50 | 2 | M47581 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GH_JAK_STAT_SIGNALING_PATHWAY | 2.56e-04 | 7 | 50 | 2 | M47646 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_JAK_STAT_SIGNALING_PATHWAY | 2.56e-04 | 7 | 50 | 2 | M47430 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_STAT5 | 2.56e-04 | 7 | 50 | 2 | M27907 | |
| Pathway | REACTOME_SIGNALING_BY_ALK_IN_CANCER | 3.24e-04 | 93 | 50 | 4 | M42521 | |
| Pathway | REACTOME_INTERLEUKIN_9_SIGNALING | 4.37e-04 | 9 | 50 | 2 | M27861 | |
| Pathway | BIOCARTA_IL22BP_PATHWAY | 4.37e-04 | 9 | 50 | 2 | MM1419 | |
| Pathway | BIOCARTA_IL22BP_PATHWAY | 4.37e-04 | 9 | 50 | 2 | M8066 | |
| Pathway | REACTOME_INTERLEUKIN_21_SIGNALING | 5.45e-04 | 10 | 50 | 2 | M27898 | |
| Pathway | REACTOME_STAT5_ACTIVATION_DOWNSTREAM_OF_FLT3_ITD_MUTANTS | 5.45e-04 | 10 | 50 | 2 | M41731 | |
| Pathway | REACTOME_INTERLEUKIN_2_SIGNALING | 5.45e-04 | 10 | 50 | 2 | MM15618 | |
| Pathway | REACTOME_SIGNALING_BY_LEPTIN | 6.64e-04 | 11 | 50 | 2 | M27195 | |
| Pathway | REACTOME_INTERLEUKIN_15_SIGNALING | 6.64e-04 | 11 | 50 | 2 | MM15578 | |
| Pathway | REACTOME_INTERLEUKIN_2_SIGNALING | 7.95e-04 | 12 | 50 | 2 | M27893 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 9.17e-04 | 54 | 50 | 3 | M29594 | |
| Pathway | REACTOME_INTERLEUKIN_15_SIGNALING | 1.09e-03 | 14 | 50 | 2 | M27858 | |
| Pathway | PID_IL5_PATHWAY | 1.09e-03 | 14 | 50 | 2 | M135 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 1.13e-03 | 58 | 50 | 3 | MM14736 | |
| Pathway | WP_FOXP3_IN_COVID19 | 1.26e-03 | 15 | 50 | 2 | M42573 | |
| Pathway | REACTOME_PROLACTIN_RECEPTOR_SIGNALING | 1.26e-03 | 15 | 50 | 2 | M552 | |
| Pathway | BIOCARTA_IL3_PATHWAY | 1.26e-03 | 15 | 50 | 2 | MM1412 | |
| Pathway | REACTOME_PENTOSE_PHOSPHATE_PATHWAY | 1.26e-03 | 15 | 50 | 2 | M27682 | |
| Pathway | BIOCARTA_IL3_PATHWAY | 1.26e-03 | 15 | 50 | 2 | M17681 | |
| Pathway | REACTOME_INTERLEUKIN_7_SIGNALING | 1.26e-03 | 15 | 50 | 2 | MM14536 | |
| Pathway | REACTOME_PENTOSE_PHOSPHATE_PATHWAY | 1.26e-03 | 15 | 50 | 2 | MM15404 | |
| Pathway | WP_MEASLES_VIRUS_INFECTION | 1.35e-03 | 136 | 50 | 4 | M42547 | |
| Pathway | REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING | 1.43e-03 | 16 | 50 | 2 | MM15710 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 1.43e-03 | 16 | 50 | 2 | M1296 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 1.43e-03 | 16 | 50 | 2 | MM1420 | |
| Pathway | REACTOME_SIGNALING_BY_FLT3_ITD_AND_TKD_MUTANTS | 1.43e-03 | 16 | 50 | 2 | M41733 | |
| Pathway | WP_IL9_SIGNALING | 1.62e-03 | 17 | 50 | 2 | M39644 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HORMONE_LIKE_CYTOKINE_TO_JAK_STAT_SIGNALING_PATHWAY | 1.62e-03 | 17 | 50 | 2 | M47905 | |
| Pathway | REACTOME_SIGNALING_BY_CYTOSOLIC_FGFR1_FUSION_MUTANTS | 1.82e-03 | 18 | 50 | 2 | M673 | |
| Pathway | REACTOME_SIGNALING_BY_FLT3_FUSION_PROTEINS | 2.03e-03 | 19 | 50 | 2 | M41732 | |
| Pathway | BIOCARTA_EPO_PATHWAY | 2.03e-03 | 19 | 50 | 2 | M12836 | |
| Pathway | REACTOME_INTERLEUKIN_20_FAMILY_SIGNALING | 2.25e-03 | 20 | 50 | 2 | MM15496 | |
| Pathway | BIOCARTA_EPO_PATHWAY | 2.25e-03 | 20 | 50 | 2 | MM1389 | |
| Pathway | REACTOME_SIGNALING_BY_KIT_IN_DISEASE | 2.25e-03 | 20 | 50 | 2 | M39002 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 2.55e-03 | 77 | 50 | 3 | M27226 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 2.65e-03 | 271 | 50 | 5 | MM15406 | |
| Pathway | BIOCARTA_IL2_PATHWAY | 2.72e-03 | 22 | 50 | 2 | M7747 | |
| Pathway | BIOCARTA_IL2_PATHWAY | 2.97e-03 | 23 | 50 | 2 | MM1411 | |
| Pathway | BIOCARTA_GLEEVEC_PATHWAY | 2.97e-03 | 23 | 50 | 2 | MM1424 | |
| Pathway | BIOCARTA_GLEEVEC_PATHWAY | 2.97e-03 | 23 | 50 | 2 | M7897 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IL2_FAMILY_TO_JAK_STAT_SIGNALING_PATHWAY | 2.97e-03 | 23 | 50 | 2 | M47904 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 3.05e-03 | 82 | 50 | 3 | MM15394 | |
| Pathway | BIOCARTA_TPO_PATHWAY | 3.24e-03 | 24 | 50 | 2 | M11520 | |
| Pathway | REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING | 3.24e-03 | 24 | 50 | 2 | M519 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 3.27e-03 | 84 | 50 | 3 | MM14929 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 3.38e-03 | 85 | 50 | 3 | M1870 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 3.44e-03 | 288 | 50 | 5 | M16864 | |
| Pathway | REACTOME_INACTIVATION_OF_CSF3_G_CSF_SIGNALING | 3.51e-03 | 25 | 50 | 2 | M41829 | |
| Pathway | BIOCARTA_TPO_PATHWAY | 3.51e-03 | 25 | 50 | 2 | MM1519 | |
| Pathway | REACTOME_SIGNALING_BY_ERYTHROPOIETIN | 3.51e-03 | 25 | 50 | 2 | M27865 | |
| Pathway | WP_IL7_SIGNALING | 3.51e-03 | 25 | 50 | 2 | M39499 | |
| Pathway | REACTOME_INTERLEUKIN_20_FAMILY_SIGNALING | 3.79e-03 | 26 | 50 | 2 | M27750 | |
| Pathway | WP_EPO_RECEPTOR_SIGNALING | 3.79e-03 | 26 | 50 | 2 | M39687 | |
| Pathway | PID_IL3_PATHWAY | 3.79e-03 | 26 | 50 | 2 | M182 | |
| Pathway | WP_EPO_RECEPTOR_SIGNALING | 3.79e-03 | 26 | 50 | 2 | MM15896 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 8.77e-08 | 475 | 76 | 10 | 31040226 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SRRT PACS1 EPRS1 RANBP2 CCNYL1 NF1 DSP SLCO4A1 GEMIN5 XPC PALB2 CCNY | 1.14e-07 | 774 | 76 | 12 | 15302935 |
| Pubmed | 1.41e-06 | 497 | 76 | 9 | 23414517 | ||
| Pubmed | SRRT PACS1 EPRS1 DMXL2 NF1 DSP INPP4A SYNE1 GEMIN5 ACTN2 CDC42BPB RPH3A WNK2 SEC13 | 2.36e-06 | 1431 | 76 | 14 | 37142655 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 23151802 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 26999798 | ||
| Pubmed | Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo. | 4.71e-06 | 2 | 76 | 2 | 20233708 | |
| Pubmed | Involvement of the STAT5 signaling pathway in the regulation of mouse preimplantation development. | 4.71e-06 | 2 | 76 | 2 | 16775227 | |
| Pubmed | A Mouse Model to Assess STAT3 and STAT5A/B Combined Inhibition in Health and Disease Conditions. | 4.71e-06 | 2 | 76 | 2 | 31443474 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 17447893 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 12377952 | ||
| Pubmed | A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development. | 4.71e-06 | 2 | 76 | 2 | 21127177 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 16289657 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 25552366 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 25470773 | ||
| Pubmed | Constitutively active Stat5A and Stat5B promote adipogenesis. | 4.71e-06 | 2 | 76 | 2 | 21431790 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 16115927 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 23275557 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 28500076 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 21826656 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 11867689 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 7720707 | ||
| Pubmed | Global analysis of IL-2 target genes: identification of chromosomal clusters of expressed genes. | 4.71e-06 | 2 | 76 | 2 | 15980098 | |
| Pubmed | STAT5A and STAT5B have opposite correlations with drug response gene expression. | 4.71e-06 | 2 | 76 | 2 | 27264955 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 15340066 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 22159083 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 20008792 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 33199496 | ||
| Pubmed | STAT5A/B gene locus undergoes amplification during human prostate cancer progression. | 4.71e-06 | 2 | 76 | 2 | 23660011 | |
| Pubmed | Role of Stat5 in type I interferon-signaling and transcriptional regulation. | 4.71e-06 | 2 | 76 | 2 | 12901872 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 28074064 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 36755813 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 16502315 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 12217382 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 25333863 | ||
| Pubmed | A role for STAT5 in the pathogenesis of IL-2-induced glucocorticoid resistance. | 4.71e-06 | 2 | 76 | 2 | 12421978 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 9852045 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 31599926 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 19966185 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 21704724 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 10594041 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 21036145 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 10486277 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 38618957 | ||
| Pubmed | Identification of human STAT5-dependent gene regulatory elements based on interspecies homology. | 4.71e-06 | 2 | 76 | 2 | 16840779 | |
| Pubmed | The role of the STAT5 proteins in the proliferation and apoptosis of the CML and AML cells. | 4.71e-06 | 2 | 76 | 2 | 15128421 | |
| Pubmed | STAT5 deficiency in hepatocytes reduces diethylnitrosamine-induced liver tumorigenesis in mice. | 4.71e-06 | 2 | 76 | 2 | 30377054 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 23565285 | ||
| Pubmed | Assessment of STAT5 as a potential therapy target in enzalutamide-resistant prostate cancer. | 4.71e-06 | 2 | 76 | 2 | 32790723 | |
| Pubmed | Characterization and cloning of STAT5 from IM-9 cells and its activation by growth hormone. | 4.71e-06 | 2 | 76 | 2 | 8732682 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 18492722 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 26717567 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 10066807 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 10835485 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 35464049 | ||
| Pubmed | The neonatal microenvironment programs innate γδ T cells through the transcription factor STAT5. | 4.71e-06 | 2 | 76 | 2 | 32281944 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 18286195 | ||
| Pubmed | Differentiating the roles of STAT5B and STAT5A in human CD4+ T cells. | 4.71e-06 | 2 | 76 | 2 | 23773921 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 8631883 | ||
| Pubmed | Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2. | 4.71e-06 | 2 | 76 | 2 | 11030348 | |
| Pubmed | Association between STAT5 polymorphisms and glioblastoma risk in Han Chinese population. | 4.71e-06 | 2 | 76 | 2 | 24878107 | |
| Pubmed | Adipocyte STAT5 deficiency does not affect blood glucose homeostasis in obese mice. | 4.71e-06 | 2 | 76 | 2 | 34818373 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 12847485 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 12835478 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 7568026 | ||
| Pubmed | Identification of STAT5A and STAT5B target genes in human T cells. | 4.71e-06 | 2 | 76 | 2 | 24497979 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 23465551 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 11756158 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 17536022 | ||
| Pubmed | STAT5 transcriptional activity is impaired by LIF in a mammary epithelial cell line. | 4.71e-06 | 2 | 76 | 2 | 17382296 | |
| Pubmed | STAT5 is essential for Akt/p70S6 kinase activity during IL-2-induced lymphocyte proliferation. | 4.71e-06 | 2 | 76 | 2 | 17911616 | |
| Pubmed | STAT5 signaling in sexually dimorphic gene expression and growth patterns. | 4.71e-06 | 2 | 76 | 2 | 10486314 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 17599554 | ||
| Pubmed | MiR-21 is under control of STAT5 but is dispensable for mammary development and lactation. | 4.71e-06 | 2 | 76 | 2 | 24497923 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 29203513 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 27367207 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 18064672 | ||
| Pubmed | Clarifying the role of Stat5 in lymphoid development and Abelson-induced transformation. | 4.71e-06 | 2 | 76 | 2 | 16493008 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 24335105 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 8816482 | ||
| Pubmed | Brain STAT5 signaling modulates learning and memory formation. | 4.71e-06 | 2 | 76 | 2 | 29460051 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 10851057 | ||
| Pubmed | Genome-wide regulation of electro-acupuncture on the neural Stat5-loss-induced obese mice. | 4.71e-06 | 2 | 76 | 2 | 28806763 | |
| Pubmed | Critical functions for STAT5 tetramers in the maturation and survival of natural killer cells. | 4.71e-06 | 2 | 76 | 2 | 29105654 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 17003334 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 17438530 | ||
| Pubmed | Differential STAT5 signaling by ligand-dependent and constitutively active cytokine receptors. | 4.71e-06 | 2 | 76 | 2 | 15677477 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 16757175 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 15677453 | ||
| Pubmed | Haploinsufficiency identifies STAT5 as a modifier of IL-7-induced lymphomas. | 4.71e-06 | 2 | 76 | 2 | 15870688 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 28606561 | ||
| Pubmed | Development of mammary luminal progenitor cells is controlled by the transcription factor STAT5A. | 4.71e-06 | 2 | 76 | 2 | 19833766 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 17317776 | ||
| Pubmed | Deregulation of STAT-5 isoforms in the development of HPV-mediated cervical carcinogenesis. | 4.71e-06 | 2 | 76 | 2 | 20415542 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 23332799 | ||
| Pubmed | Cell intrinsic defects in cytokine responsiveness of STAT5-deficient hematopoietic stem cells. | 4.71e-06 | 2 | 76 | 2 | 12393407 | |
| Pubmed | [Effect of STAT5 gene silencing on the proliferation of T lymphocytes in a mouse model of asthma]. | 4.71e-06 | 2 | 76 | 2 | 22455944 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 12039059 | ||
| Pubmed | The Role of STAT5 in Tyrosine Kinase Inhibitor (IMATINIB) Resistance in CML Patients. | 4.71e-06 | 2 | 76 | 2 | 32041920 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 17976521 | ||
| GeneFamily | WD repeat domain containing | 1.02e-04 | 262 | 52 | 6 | 362 | |
| GeneFamily | Cyclins | 2.92e-03 | 28 | 52 | 2 | 473 | |
| GeneFamily | Nucleoporins | 3.81e-03 | 32 | 52 | 2 | 1051 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 6.19e-03 | 41 | 52 | 2 | 1298 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.17e-06 | 199 | 76 | 6 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-05 | 185 | 76 | 5 | 53854a9ec87c24c360541c83d86d8fafb303ad58 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-05 | 185 | 76 | 5 | a61fc7a3700a1efcf640bef7680c0443ee148a46 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 1.62e-05 | 185 | 76 | 5 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.80e-05 | 189 | 76 | 5 | b6b4da51bc7f2c13a2f940540fdc61027d084835 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-05 | 191 | 76 | 5 | 5a5b5402a077b3189ca156f2bac5f47ad780aebf | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-05 | 191 | 76 | 5 | 78bcce497920cc5b3bef083eab50deb1cc82cd2e | |
| ToppCell | facs-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-05 | 191 | 76 | 5 | c06bbad24e4897b2c3b5015e4de02411ebf75367 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-05 | 191 | 76 | 5 | 5f43f98cfe7a08d61ed55f34808fabfe47f1ac2e | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.99e-05 | 193 | 76 | 5 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type | 2.14e-05 | 196 | 76 | 5 | 4ac4073380d939a73cec7413e9f3f5ef616d2924 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial|LPS_only / Treatment groups by lineage, cell group, cell type | 2.25e-05 | 198 | 76 | 5 | e035380578c01b0243bfef29ca9b50cc17cce771 | |
| ToppCell | LPS_only-Epithelial_airway|LPS_only / Treatment groups by lineage, cell group, cell type | 2.25e-05 | 198 | 76 | 5 | ba090210392e001a3f7bdf09371b3f0e0c8c7ef3 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_basal-Suprabasal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.36e-05 | 200 | 76 | 5 | ce969c958a31145bbfe315a9a865d7900ecc9549 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 1.30e-04 | 151 | 76 | 4 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | facs-Brain_Myeloid-Cortex-3m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 153 | 76 | 4 | 0ef7c45cdd854c79e527006034029767f8e108b2 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 158 | 76 | 4 | 12661763d1c309106801cb710c04cd2b62d16cba | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial-epithelial_cell_of_thymus|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 158 | 76 | 4 | e7db50d6dfaf7280a73a0d5b5aa4f43ea2762d72 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial-TECs|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 158 | 76 | 4 | 0792c39e6fc0745095af7812de2d50949540d60f | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-04 | 165 | 76 | 4 | 84eca6a0f5e996b6955ae79fa102af239098fe8f | |
| ToppCell | control-Plasmablast|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.82e-04 | 165 | 76 | 4 | 61063e0ce61bc92d5d1093be8279af03f650720b | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-04 | 165 | 76 | 4 | af59a095ecc6758abc13d763c00e44447c488167 | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.91e-04 | 167 | 76 | 4 | 7efa0081e79f22b219eac64ffcaedb2179cde299 | |
| ToppCell | Club_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 1.91e-04 | 167 | 76 | 4 | dbdaaeb3bd9139cb008d9fe24ec031fc5628f136 | |
| ToppCell | droplet-Heart-nan-18m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-04 | 168 | 76 | 4 | 2201ae834b53cbdc085f8f02607fa5b5bd911268 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-04 | 169 | 76 | 4 | a5964aef04093b460bbe29d5e2e7389f8fd2d46f | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-04 | 169 | 76 | 4 | e0076aa61b4ef3f836f5750005d0469d3982eb6d | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 2.04e-04 | 170 | 76 | 4 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.04e-04 | 170 | 76 | 4 | f0b0d2d0402de3ed7322284a599646db43475761 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.04e-04 | 170 | 76 | 4 | 054360a3b05f5e41221c98b122d241b1affad26a | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_A2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.28e-04 | 175 | 76 | 4 | 334fad1a147de6c007cec5089c02c35cf3220f1b | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_A2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.28e-04 | 175 | 76 | 4 | da191dfb8a7f976a632a3a0b923942ab54f5c8c1 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_goblet_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.38e-04 | 177 | 76 | 4 | a4c001a8e44142babf9f24dfe6f7b73a70b11b16 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_goblet_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.38e-04 | 177 | 76 | 4 | 363e07b0f347f3716d530a28ead854b98e27d37c | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.54e-04 | 180 | 76 | 4 | ca2a35bfb67347e47f511589a3d0f763e6664634 | |
| ToppCell | renal_papilla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.54e-04 | 180 | 76 | 4 | 49829e833fe6d2431cfd2e8f378c2aaa3b2b46a4 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.54e-04 | 180 | 76 | 4 | 4e9e8cde2919610c4ac0025b1c9819808048bc1d | |
| ToppCell | HSPCs-Neutro_prog.|HSPCs / Lineage and Cell class | 2.54e-04 | 180 | 76 | 4 | 328192f4678dcdc01c806362b225e770d23498d6 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.54e-04 | 180 | 76 | 4 | 466381bf93c3da6a2a241daadb68e9aad2964eae | |
| ToppCell | COVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.59e-04 | 181 | 76 | 4 | c5f9c92af1384d9089c65afdf41c6feb8345a3ae | |
| ToppCell | HSPCs-Neutro_prog.|World / Lineage and Cell class | 2.65e-04 | 182 | 76 | 4 | f2512354b90f55bf4172c28084bf52cf79e41d8a | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-04 | 183 | 76 | 4 | 03c7e69136d5a3b9c5b2c91733e9b1c791f45c49 | |
| ToppCell | Substantia_nigra-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6_(Thalamus,_glutamatergic)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.75e-04 | 74 | 76 | 3 | ef4c9eafc794c7d50aef28b37d21b52d3c511499 | |
| ToppCell | Substantia_nigra-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6_(Thalamus,_glutamatergic)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.75e-04 | 74 | 76 | 3 | 6ecbdf4186039a031410e09ecd5afa66b6d5e2dc | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.76e-04 | 184 | 76 | 4 | a8c6028d745aaa6ee7842259238694cb50ce0526 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.76e-04 | 184 | 76 | 4 | 081d045f3bc98a36f342de7d50f39c9a888dd7eb | |
| ToppCell | Control-Myeloid_G-immature_Neutrophil|Control / Disease group, lineage and cell class | 2.76e-04 | 184 | 76 | 4 | 45f873236f7e90fb78c8e291d3b5b92d121acec9 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.76e-04 | 184 | 76 | 4 | 84c20730cd92b9aaa50077d7b625e37e7f9e91d2 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.76e-04 | 184 | 76 | 4 | d31d4116d1d196633784863781fa45673607a421 | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 2.76e-04 | 184 | 76 | 4 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | Ciliated_cells-A-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.76e-04 | 184 | 76 | 4 | 07c5a9633ccdcd18771e3230d6198a55c400afa6 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.82e-04 | 185 | 76 | 4 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-04 | 185 | 76 | 4 | af86e75096c1812ae27a78405355957ee8043d84 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.82e-04 | 185 | 76 | 4 | e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3 | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.88e-04 | 186 | 76 | 4 | 4046b701aa29712d9f7c774f8955215122c3c003 | |
| ToppCell | COPD-Epithelial-Goblet|World / Disease state, Lineage and Cell class | 2.88e-04 | 186 | 76 | 4 | d75fe7640a4b2c450c9759a1b3c3ef2a087f0092 | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.88e-04 | 186 | 76 | 4 | bd5837033c1ffcbe5dd30195cc4846a2ba351bcd | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-Granular_Neuron_CB_Gabra6|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.88e-04 | 186 | 76 | 4 | d6c8ce2a32c218dcc63d861cc247152430ed3c8c | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-effector_CD4-positive,_alpha-beta_T_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.94e-04 | 187 | 76 | 4 | e61c1755531469dd3850c9740474b5ad4e0499c1 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.00e-04 | 188 | 76 | 4 | 3177b2c1723268d330d3e9f24f9e24492ace6286 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 3.00e-04 | 188 | 76 | 4 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Adult / Lineage, Cell type, age group and donor | 3.00e-04 | 188 | 76 | 4 | e5cad03f4a64147fe8174e7f614cf45233ffb9b7 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.00e-04 | 188 | 76 | 4 | beb2df2332a46cc81b10e8e29fc9829020111f03 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-04 | 188 | 76 | 4 | 14e120b20e76baa07b6510a94f0c2dcdfdd52357 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 3.06e-04 | 189 | 76 | 4 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-04 | 189 | 76 | 4 | 443359d90fafae0c1de6bdcce9e8c95df6ea4de8 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.06e-04 | 189 | 76 | 4 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 3.06e-04 | 189 | 76 | 4 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | Adult|World / Lineage, Cell type, age group and donor | 3.06e-04 | 189 | 76 | 4 | 5cd285bfad973125d46d704fec18b21266a63379 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-04 | 190 | 76 | 4 | c247562df3e1aa3173c9f01a74d5831f0764a1b2 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 3.12e-04 | 190 | 76 | 4 | f1363f7806cfc4f14fbc1b0e8dac2de813a88eee | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.12e-04 | 190 | 76 | 4 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-04 | 190 | 76 | 4 | 5cea8298c8336c136ba009630c9e48d4bc832cb2 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-04 | 191 | 76 | 4 | b94e66ac71e73f46b0323d424e7b8b906751d584 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.18e-04 | 191 | 76 | 4 | 08042952431ca1a6fd7dfc13f36eb28643979598 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.18e-04 | 191 | 76 | 4 | f229abf69a1217194f74b0502486907e07dba989 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.18e-04 | 191 | 76 | 4 | 63aa671837b79d2feb7ed1e67712cc01caf72bef | |
| ToppCell | RV-08._Macrophage|World / Chamber and Cluster_Paper | 3.24e-04 | 192 | 76 | 4 | a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.24e-04 | 192 | 76 | 4 | be592e661367affced9ebe80849b466e6adb3a34 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.24e-04 | 192 | 76 | 4 | e19e3e8edcc08e4a67873bfb6e46489ca6c8756a | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 3.24e-04 | 192 | 76 | 4 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.24e-04 | 192 | 76 | 4 | 61c2caf6c838132ed5faa8791c288f2149eba2c8 | |
| ToppCell | COPD-Epithelial-Goblet|COPD / Disease state, Lineage and Cell class | 3.24e-04 | 192 | 76 | 4 | 93b2ca0a97776d28c7e8f1a0642c4b63a5554aab | |
| ToppCell | facs-Lung-nan-3m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.24e-04 | 192 | 76 | 4 | cca2d0fedfbd946c54d6f4fc45887117c8dae58a | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 3.31e-04 | 193 | 76 | 4 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | Club_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.31e-04 | 193 | 76 | 4 | 6582c0367052b9d10fb629c383ee0c55872afd2d | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 3.31e-04 | 193 | 76 | 4 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | COVID-19-Endothelial_cells-Inflamed_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 3.31e-04 | 193 | 76 | 4 | 979ebefa527f86bebeea5d94e626ee6c1cc7d53b | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.31e-04 | 193 | 76 | 4 | 0b62a6ddd7c42efd9f39781971d1438501e1fa8d | |
| ToppCell | Club_cells|World / lung cells shred on cell class, cell subclass, sample id | 3.31e-04 | 193 | 76 | 4 | 9d3165dc5763a07a7d873f497624d9d6528fa2db | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.37e-04 | 194 | 76 | 4 | 81713e0409e8be695ba5dfdc67a997b33435dd9e | |
| ToppCell | IPF-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 3.37e-04 | 194 | 76 | 4 | 777ce41c3f22c591e2d81120f189b834e53ffb4b | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 3.37e-04 | 194 | 76 | 4 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.37e-04 | 194 | 76 | 4 | 627cffe2d448e74fc5df92e74e5b922a73304137 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 3.44e-04 | 195 | 76 | 4 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 3.44e-04 | 195 | 76 | 4 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | proximal-Endothelial-Capillary_Aerocyte|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.44e-04 | 195 | 76 | 4 | f1cbf82484f489fe7e0b5de6a49ea28d69f04e1a | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 3.44e-04 | 195 | 76 | 4 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | proximal-Endothelial-Capillary_Aerocyte-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.44e-04 | 195 | 76 | 4 | 13168c9632b58dd65ecb365df3832d95e7325919 | |
| ToppCell | proximal-3-Endothelial-Capillary_Aerocyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.44e-04 | 195 | 76 | 4 | 36b2e754ed7ff138ac05fb51f4494e5339669828 | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 1.72e-04 | 8 | 74 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | arrhythmogenic right ventricular cardiomyopathy (is_implicated_in) | 2.76e-04 | 10 | 74 | 2 | DOID:0050431 (is_implicated_in) | |
| Disease | cerebral cavernous malformation (implicated_via_orthology) | 3.36e-04 | 11 | 74 | 2 | DOID:0060669 (implicated_via_orthology) | |
| Disease | Basal cell carcinoma | 3.36e-04 | 11 | 74 | 2 | C0007117 | |
| Disease | Moyamoya Disease | 8.24e-04 | 17 | 74 | 2 | C0026654 | |
| Disease | Uterine leiomyoma | 1.57e-03 | 91 | 74 | 3 | HP_0000131 | |
| Disease | colon adenocarcinoma (is_implicated_in) | 1.94e-03 | 26 | 74 | 2 | DOID:234 (is_implicated_in) | |
| Disease | gastric adenocarcinoma (is_marker_for) | 2.25e-03 | 28 | 74 | 2 | DOID:3717 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| WDSWVLKAFDSQCQI | 246 | O14727 | |
| EIQVWNWQLDKCIFL | 1026 | O14727 | |
| WAIKDFQECTWQVVL | 36 | Q6ZRH7 | |
| QEIWVCEKQTITKWP | 581 | Q9UG63 | |
| LCDLVWANEKAWFQT | 401 | Q9Y6F8 | |
| KHGIVVDWDCVQDIW | 116 | Q9Y614 | |
| WEKQQRKTFTAWCNS | 36 | P35609 | |
| WWKEIVATILFCIIA | 521 | Q9NZJ5 | |
| NQLWKKWVCDVSTTL | 1891 | Q7Z2Y8 | |
| CDCQTWKNWLQKITE | 476 | Q9P2G1 | |
| WQCGQWVEVVIDDRL | 131 | Q6MZZ7 | |
| VWDDQAVWNVDYCQI | 226 | Q8ND76 | |
| VLNDWKCVWQCKTSV | 156 | Q8TDJ6 | |
| LVFDAWTKAACAWEQ | 111 | P51828 | |
| EWIAPAFCQWFVKEI | 111 | Q8IVL8 | |
| VWDDQAVWNVDYCQI | 246 | Q8N7R7 | |
| DAEVQKVCIWKWTLA | 366 | Q8TBY9 | |
| IVLICVWWQNGEWQA | 241 | Q8TD07 | |
| KQLCTERQKSWWDAV | 521 | P49792 | |
| VDVWKWCNLSEFIVY | 51 | O60896 | |
| EWEKVWLNVDKSLEC | 526 | Q96PE3 | |
| VAVNCSTEWKWLVDR | 361 | A0AUZ9 | |
| ANDKLWFWLEVNSVV | 236 | Q12791 | |
| VAAVVWKIKQSCWAS | 1296 | O75882 | |
| CAVWWTKEFELFHNQ | 506 | O43451 | |
| KWRNVTQEKSGWVEC | 636 | Q2LD37 | |
| ERTEDVWQKIQWCLV | 646 | Q8ND23 | |
| WLISEEEKTQKNQCW | 61 | Q9UK99 | |
| PWAVVKCLFENVQCW | 281 | P47871 | |
| WVHQACLQRWVDEKQ | 41 | Q9NX47 | |
| VLECSWDELWNKVQQ | 726 | Q96CW5 | |
| CKTEGWADQIVLQWE | 301 | Q9Y546 | |
| WNKENRFCSWVDQKL | 16 | P07738 | |
| FEVWLEQATEIVKEW | 181 | Q9UL42 | |
| VAHWEAQIAEIIQWV | 811 | Q9Y5S2 | |
| VEWSDIKFFQLAAQW | 931 | Q6VY07 | |
| CEDVVSLWKALDAWQ | 891 | Q86YC2 | |
| IQDNLDAWLKCQATW | 1076 | Q8TD57 | |
| TQWSWILQITKCIDV | 356 | P15924 | |
| LVAAVVWKIKQTCWA | 1246 | Q5VV63 | |
| LENWNIQTATWLKCV | 346 | Q6ZNC8 | |
| DAWTYCISKNEWIQF | 296 | Q9Y2U9 | |
| VWIFAQSVKDPWVLC | 841 | Q5TBA9 | |
| QWNKVISACTEVWQT | 86 | Q9UKT8 | |
| EVWQTACKNLGWQID | 96 | Q9UKT8 | |
| EWQAAWLLKAVTFID | 41 | Q9Y315 | |
| LIKICQEFNSTWAWE | 91 | Q96T23 | |
| QVDWKDWKIGFQLCN | 216 | P37088 | |
| VTLWKESVDGQWVCI | 286 | P55735 | |
| LWDEDFVQWKVVETL | 976 | Q9Y3M8 | |
| PIKLNQWCNVVRWEF | 1141 | P07814 | |
| WCVVLVLQVVQWKSE | 176 | Q7Z7N9 | |
| SVWLCKICIEQREVW | 136 | Q9Y2J0 | |
| EWAVFSEKNKELCEW | 7781 | Q8NF91 | |
| KWIWFENSKNISFEC | 1641 | B5MCY1 | |
| VPDQTWVQCDECLKW | 421 | Q8TE76 | |
| QSWCEKLAEIIWQNR | 276 | P51692 | |
| VQWVVQKVAWFLQIT | 281 | O43868 | |
| EDSCWQWFVIYTKQA | 351 | Q8N9S9 | |
| WVIDKACLLWQDQCG | 636 | Q96BD0 | |
| QSWCEKLAEIIWQNR | 276 | P42229 | |
| WVTFDRSVNIKEICW | 466 | Q9BXP5 | |
| EKWQKSIVEELCAWV | 3181 | Q63HN8 | |
| LEVVVERNLCWEWYQ | 1291 | Q96RL7 | |
| LENICLWKNWESIGE | 76 | Q8TB69 | |
| CKVDDFSWAWNVVYI | 346 | C9JQI7 | |
| VLQWIRENIAEWKNC | 151 | P11908 | |
| WLWAVEAFAKQLCFQ | 961 | Q8TEQ6 | |
| AVINSLEKAFWNWVE | 211 | P21359 | |
| QWFRKTAWNLAVQCD | 636 | Q8IYF3 | |
| TSDLACKLWVWQVEG | 701 | Q6ZN44 | |
| EDLICWQIWEQFTSK | 101 | A6NK53 | |
| EEWSCQQIWEQIAKD | 96 | Q12901 | |
| ETWVEVAWCELQDRK | 216 | Q9Y3S1 | |
| WLEVFCEQEEKWVCV | 531 | Q01831 | |
| CQLKICSEWQIRTDW | 731 | Q6ZMP0 | |
| WNEAFVAAKECLQWD | 31 | O15050 | |
| LSQEVLHCWQIWKQR | 66 | Q96NJ3 | |
| QWWECKFIAEGIIDQ | 526 | Q5T447 |